Form 4: Disc Medicine Director, Mark Chin, Acquires 10,000 Stock Options
SEC Form 4 Filing
Director Mark Chin acquired 10,000 stock options in Disc Medicine, Inc. on June 12, 2024.
Summary
- Mark Chin, a director of Disc Medicine, Inc. (IRON), acquired 10,000 stock options on June 12, 2024.
- The exercise price of these options is $38.85.
- The options vest upon the earlier of the company's 2025 annual meeting or the one-year anniversary of the grant date, contingent on continued service.
- Following the transaction, Chin beneficially owns 10,000 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral filing related to stock option grants, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment as it indicates confidence from a director.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of transaction: Mark Chin acquired 10,000 stock options. |
| 06/14/2024 | Date of Form 4 filing. |
| 06/11/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.